Epstein-Barr Virus (EBV) in Extranodal T-cell Non-Hodgkin's Lymphomas (T-NHL). Identification of Nasal T-NHL as a Distinct Clinicopathological Entity Associated with EBV

References

• Sullivan L. J. Epstein-Barr virus and lymphoproliferative disorders. Seminars in Hematol 1988; 25: 269–278
   PubMed Web of Science ®Google Scholar
• Ring C. I. A. The B-cell immoralizing functions of Epstein-Barr virus. J. Gen. Virol 1994; 75: 1–13
   PubMed Web of Science ®Google Scholar
• Herbst H., Stein H., Niedobitek G. Epstein-Barr virus and CD30 positive malignant lymphomas. Crit. Rev. Oncogenesis 1993; 4: 191–239
   PubMed Web of Science ®Google Scholar
• Young L. S., Alfieri C., Hennessy K. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med 1989; 321: 1080–1089
   PubMed Web of Science ®Google Scholar
• Ho M., Miller G., Atchinson R. W. Epstein-Barr virus infection and DNA hybridisation studies in post transplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J. Infect. Dis 1985; 152: 876–886
   PubMed Web of Science ®Google Scholar
• Zur-Hausen H., Shulte-Holthausen H., Klein E. EBV-DNA in Burkitt's lymphoma and anaplastic carcinoma of the nasopharynx. Nature 1970; 228: 1056–1058
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S. J., Rea D., Raphael M. Epstein-Barr virus latent gene expression and tumour cell phenotype in acquired immunodeficiency syndrome related non-Hodgkin's lymphoma. Amer. J. Pathol 1993; 143: 1072–1085
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Herbst H., Niedobitek G., Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74: 810–816
   PubMed Web of Science ®Google Scholar
• Herbst H., Niedobitek G., Kneba M. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am. J. Pathol 1990; 137: 13–18
   PubMed Web of Science ®Google Scholar
• Brousset P., Chittal S., Schlaifer D. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections. Blood 1991; 77: 1781–1786
   PubMed Web of Science ®Google Scholar
• Karameris A., Kanavaros P. Demonstration of Epstein-Barr virus genome in neoplastic cells of Hodgkin's disease by in situ hybridization in paraffin sections, using biotinylated probes. A study of 46 cases. Pathol Res. Pract 1992; 188: 310–314
   PubMed Web of Science ®Google Scholar
• Oshima K., Kikuchi M., Eguchi F. Analysis of Epstein-Barr viral genomes using Southern blotting, polymerase chain reaction and in situ hybridization. Virchows Archiv. (B) 1990; 59: 383–390
   Web of Science ®Google Scholar
• Weiss L. M., Movahed L. A., Warnke R. A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Stemberg cells of Hodgkin's disease. N. Engl. J. Med 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Jiwa N. M., Kanavaros P., de Bruin P. Presence of Epstein Barr virus harbouring small and intermediate sized cells in Hodgkin's disease. Is there a relationship with Reed-Sternberg cells?. J. Pathol 1993; 169: 129–136
   Web of Science ®Google Scholar
• Herbst H., Dallenbach F., Hummel M. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA 1991; 88: 4766–4770
   PubMed Web of Science ®Google Scholar
• Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831–840
   PubMed Web of Science ®Google Scholar
• Klein G. Viral latency and transformation. The strategy of Epstein-Barr virus. Cell 1989; 58: 5–8
   PubMed Web of Science ®Google Scholar
• Fahraeus R., Rymo L., Rhim J. S., Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990; 345: 447–449
   PubMed Web of Science ®Google Scholar
• Dawson C. W., Rickinson A. B., Young L. S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990; 344: 777–780
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Gregory C. Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein I protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar
• Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in the tumor cells of Hodgkin's disease. Lancet 1991; 337: 320–322
   PubMed Web of Science ®Google Scholar
• Su I. J., Hsieh H. C., Lin K. H. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991; 77: 799–808
   PubMed Web of Science ®Google Scholar
• Herbst H., Dallenbach F., Hummel M. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)- positive anaplastic large cell lymphomas. Blood 1991; 78: 2666–2673
   PubMed Web of Science ®Google Scholar
• Harabuchi Y., Yamanaka N., Kataura A. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128–130
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S. J., Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am. J. Pathol 1992; 140: 1315–1325
   PubMed Web of Science ®Google Scholar
• Korbjuhn P., Anagnostopoulos I., Hummel M. Frequent latent Epstein Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus negative european peripheral pleomorphic T-cell lymphomas. Blood 1993; 82: 217–223
   PubMed Web of Science ®Google Scholar
• Zhou N. G., Hamilton-Dutoit S. J., Yan O. H., Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathol 1993; 24: 115–122
   Web of Science ®Google Scholar
• de Bruin P. C., Jiwa N. M., Van der Valk P. Detection of Epstein Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: Relation between latent membrane protein-1 positivity and clinical course. Histopathol 1993; 23: 509–518
   PubMed Web of Science ®Google Scholar
• de Bruin P. C., Jiwa N. M., Oudejans J. Presence of Epstein Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 1994; 83: 1612–1618
   PubMed Web of Science ®Google Scholar
• Sabourin J. C., Kanavaros P., Briere J. Epstein Barr-virus genomes and EBV-encoded latent membrane protein in pulmonary lymphomas occuring in non-immunocompromised patients. Am. J. Surg. Pathol 1993; 17: 995–1002
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Lescs M. C., Briere J. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695
   PubMed Web of Science ®Google Scholar
• Frierson H. F., Innes D. J., Mills S. E., Wick M. R. Immunophenotypic analysis of sinonasal non-Hodgkin's lymphomas. Hum. Pathol 1989; 20: 636–640
   PubMed Web of Science ®Google Scholar
• Lippman S. M., Grogan T. M., Spier C. M. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer 1987; 59: 936–939
   PubMed Web of Science ®Google Scholar
• Ferry J. A., Sklar J., Zukerberg L. R., Harris N. L. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am. J. Surg. Pathol 1991; 15: 268–279
   PubMed Web of Science ®Google Scholar
• Campo E., Cardesa A., Alos L. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses. An immunohisto-chemical study. Am. J. Clin. Pathol 1991; 96: 184–191
   PubMed Web of Science ®Google Scholar
• Ho F. C. S., Todd D., Loke S. L., Ng R. P., Khoo R. K. K. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, a retrospective study covering an eight year period. Int. J. Cancer 1984; 34: 143–148
   PubMed Web of Science ®Google Scholar
• Chan J. K. C., Ng C. S., Lau W. H., Lo S. T. H. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am. J. Surg. Pathol 1987; 11: 418–429
   PubMed Web of Science ®Google Scholar
• Eichel B. S., Harrison E. G., Devine K. D., Scanlon P. W., Brown H. A. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am. J. Surg 1966; 112: 597–602
   PubMed Web of Science ®Google Scholar
• Lipford E. H., Margolick J. B., Longo D. L., Fauci A. S., Jaffe E. S. Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 1988; 72: 1674–1681
   PubMed Web of Science ®Google Scholar
• Gaulard P., Henni T., Marolleau J. P. Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell disorder. Cancer 1988; 62: 705–720
   PubMed Web of Science ®Google Scholar
• Medeiros L. J., Peiper S. C., Elwood L., Yano T., Raffeld M., Jaffe E. S. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum. Pathol 1991; 22: 1150–1157
   PubMed Web of Science ®Google Scholar
• Ng C. S., Chan J. K. C., Hui P. K., Chan W. C., Lo S. T. H. Application of a T-cell receptor antibody βF1 for immunophenotypic analysis of malignant lymphomas. Am. J. Pathol 1988; 132: 365–371
   PubMed Web of Science ®Google Scholar
• Ng C. S., Chan J. K. C., Lo S. T. H. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum. Pathol 1987; 18: 1257–1262
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Picker L. J., Grogan T. M., Warnke R. A., Sklar J. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am. J. Pathol 1988; 130: 436–443
   PubMed Web of Science ®Google Scholar
• Ho F. C. S., Srivastava G., Loke S. L. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol. Oncol 1990; 8: 271–281
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Gaffey M. J., Chen Y.-Y., Frierson H. F. Frequency of Epstein-Barr viral DNA in “Western” sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am. J. Surg. Pathol 1992; 16: 156–162
   PubMed Web of Science ®Google Scholar
• Medeiros L. J., Jaffe E. S., Chen Y.-Y., Weiss L. M. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am. J. Surg. Pathol 1992; 16: 439–447
   PubMed Web of Science ®Google Scholar
• Arber D. A., Weiss L. M., Albujar P. F., Chen Y. Y., Jaffe E. S. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein Barr virus infection. Am. J. Surg. Pathol 1993; 17: 392–399
   PubMed Web of Science ®Google Scholar
• Herbert A., Wright D. H., Isaacson P. G., Smith J. L. Primary malignant lymphoma of the lung: histopathologic and immunologic evaluation of nine cases. Hum. Pathol 1984; 15: 415–422
   PubMed Web of Science ®Google Scholar
• Liebow A. A., Carrington C. B., Friedman R. J. Lymphomatoid granulomatosis. Hum. Pathol 1972; 3: 457–548
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Pathologic and clinical spectrum of post-thymic malignancies. Cancer Invest 1984; 2: 413–426
   PubMed Web of Science ®Google Scholar
• Katzenstein A., Peiper S. C. Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: analysis of 29 cases by the polymerase chain reaction technique. Mod. Pathol 1990; 3: 435–441
   PubMed Web of Science ®Google Scholar
• Menarguez M., Mollejo M., Carrion R. Waldeyer ring lymphomas. A clinicopathological study of 79 cases. Histopathol 1994; 24: 13–22
   PubMed Web of Science ®Google Scholar
• Isaacson P., Spencer J. Malignant lymphoma of mucosa associated lymphoid tissue. Histopathol 1987; 11: 445–453
   PubMed Web of Science ®Google Scholar
• Pan L., Diss T. C., Peng H. Epstein-Barr virus in enteropathy associated T-cell lymphoma. J. Pathol 1993; 170: 137–143
   PubMed Web of Science ®Google Scholar
• Willemze R., Beljaards R. C., Meijer C. J. L. M. Classification of primary cutaneous T-cell lymphomas. Histopathol 1994; 24: 405–415
   PubMed Web of Science ®Google Scholar
• Lee P., Charley M., Tharp M., Jegasothy B., Deng J. S. Possible role of Epstein Barr virus infection in cutaneous T-cell lymphomas. J. Invest. Dermatol 1990; 95: 309–312
   PubMed Web of Science ®Google Scholar
• Borisch B., Boni J., Burki K., Laisue J. A. Recurrent cutaneous anaplastic large cell (CD30+) lymphoma associated with Epstein-Barr virus. Am. J. Surg. Pathol 1992; 16: 796–801
   PubMed Web of Science ®Google Scholar
• Ott G., Ott M. M., Feller A. C., Seidl S., Muller-Hermenlink H. K. Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int. J. Cancer 1992; 51: 562–567
   PubMed Web of Science ®Google Scholar
• Su I. J., Tsai T. F., Cheng A. L., Chen C. C. Cutaneous manifestations of Epstein-Barr virus associated T-cell lymphoma. J. Am. Acad. Dermatol 1993; 29: 685–692
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Loannidou D., Tzardi M. (in press) Mycosis Fungoides: expression of c-myc, p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol. Res. Pract
   Web of Science ®Google Scholar
• Kanavaros P., Sakalidou A., Tzardi M. (in press) Frequent detection of Epstein-Barr virus encoded EBER mRNAs and LMPI protein in neoplastic cells of Hodgkin's disease arising in childhood. Pathol. Res. Pract
   Google Scholar
• Lennert K., Feller A. C. Histopathology of non-Hodgkin's lymphomas. Springer Verlag, Berlin 1992
   Google Scholar
• Pals S., Horst E., Scheper R. J., Meijer C. J. L. M. Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease. Immunol. Rev 1989; 108: 111–123
   PubMed Web of Science ®Google Scholar
• Noorduyn L. A., Beljaards R. C., Pals S. T. Differential expression of the Heca-452 antigen (cutaneous lymphocyte associated antigen CLA) in cutaneous and non-cutaneous T-cell lymphomas. Histopathol 1992; 21: 59–64
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Hummel M., Kaudewitz P. Detection of HTLV-1 proviral sequences in CD30 positive large cell cutaneous T-cell lymphomas. Am. J. Pathol 1990; 137: 1317–1322
   PubMed Web of Science ®Google Scholar
• de Bruin P. C., Beljaards R. C., van Heerde P. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal large cell anaplastic lymphoma of T-cell or null cell phenotype. Hispathol 1993; 23: 127–134
   PubMed Web of Science ®Google Scholar
• Soler J., Bordes R., Ortuno F. Aggressive naturål killer leukaemia/lymphoma in two patients with lethal medline granuloma. Br. J. Haematol 1994; 86: 659–662
   PubMed Web of Science ®Google Scholar
• Hellquist H. B. Pathology of the nose and paranasal sinuses. Butterworths, Editions 1990; 1–12
   Google Scholar
• Winther B., Innes D. J., Mills S. E. Lymphocyte subsets in normal airway mucosa of the human nose. Arch. Otolaryngol. Head Neck Surg 1987; 113: 59–62
   PubMed Web of Science ®Google Scholar
• Robertson M. J., Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76: 2421–2438
   PubMed Web of Science ®Google Scholar
• Borisch B., Hennig I., Laeng R. H. Association of Epstein-Barr virus with T-cell non-Hodgkin lymphoma of the midline granuloma type. Blood 1993; 82: 858–864
   PubMed Web of Science ®Google Scholar
• Sixbey J. W., Shirley P., Chesney P. J., Buntin D. M., Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989; 2: 761–763
   PubMed Web of Science ®Google Scholar
• Jones J. F., Shorin S., Abramowsky C. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein Barr virus infections. N. Engl. J. Med 1988; 318: 733–741
   PubMed Web of Science ®Google Scholar
• Kadin M. E., Vonderheid E. C., Weiss L. M. Absence of Epstein-Barr viral RNA in lymphomatoid papulosis. J. Pathol 1993; 170: 145–148
   PubMed Web of Science ®Google Scholar
• Tsoukas C. D., Lambris J. D. Expression of EBV/C3d receptors on T-cells: biological significance. Immunol. Today 1993; 14: 56–59
   PubMedGoogle Scholar
• Ott G., Kirchner T., Seidl S., Muller-Hermelink H. K. Primary gastric lymphoma is rarely associated with Epstein-Barr virus. Virchows Archiv. B Cell Pathol 1993; 64: 287–294
   Google Scholar
• Della D., Borrelo M. G., Berti E. Clonal immunoglobuline gene rearrangements and normal T-cell receptor, bcl-2 and c-myc genes in cutaneous B-cell lymphomas. Cancer Res 1989; 49: 4901–4905
   PubMed Web of Science ®Google Scholar
• Niedobitek G., Young L. S. Epstein-Barr virus persistence and virus associated tumours. Lancet 1994; 343: 333–335
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Jiwa M., De Bruin P. High incidence of EBV genome in CD30 positive non-Hodgkin's lymphomas. J. Pathol 1992; 168: 307–315
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Jiwa M., Van der Valk P. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt preexisting immunodeficiency. Hum. Pathol 1993; 24: 725–729
   PubMed Web of Science ®Google Scholar
• Jiwa N. M., Kanavaros P., Van der Valk P. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus. J. Clin. Pathol 1993; 46: 211–217
   PubMed Web of Science ®Google Scholar
• Stein H., Mason D. Y., Gerdes J. The expression of Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue. Evidence that Reed-Stemberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–859
   PubMed Web of Science ®Google Scholar
• Durkop H., Latza U., Hummel M. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic of Hodgkin's disease. Cell 1992; 68: 421–430
   PubMed Web of Science ®Google Scholar
• Smith C. A., Gruss H. J., Davis T. CD 30 antigen, a marker for Hodgkin's lymphoma is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73: 1349
   PubMed Web of Science ®Google Scholar
• Gruss H. J., Boiani N., Williams D. E. Pleotropic effects of the CD30 ligand on CD30 expressing cells and lymphoma cell lines. Blood 1994; 83: 2045–2056
   PubMed Web of Science ®Google Scholar